RecruitingNCT06662929

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

Arabic Patient-reported Outcome Measures During Radiotherapy for Head and Neck Cancer: a Validation Study

Sponsor

King Saud University

Enrollment

125 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Neoplasms Oral Cancer Nasopharyngeal Cancer Oropharynx Cancer Tongue Cancer Oral Neoplasm

Summary

The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are: * To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients. * To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics. The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and validating patient-reported outcome questionnaires in Arabic to better measure quality of life, symptoms, and daily functioning in patients with head and neck cancer who are undergoing or have completed radiation therapy. Having reliable tools in Arabic helps ensure Arabic-speaking patients can accurately describe how treatment is affecting their daily lives. **You may be eligible if...** - You are 18 years old or older - You are currently receiving, planning to receive, or have already received radiation therapy for head and neck cancer at King Saud University Medical City **You may NOT be eligible if...** - You are under 18 years old - You have a serious illness (such as heart failure) that would interfere with participation - You are not able to read, understand, or sign an informed consent form Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.